Picosen Micra rectal gel 0.12 g/10 g microclyster in 10 g cannula tubes 6 pcs

• active ingredient: 1 g of gel contains 12 mg of docusate sodium;
• excipients: glycerin, sodium carboxymethylcellulose, purified water.

Hypersensitivity to any of the components of the drug.

Intestinal obstruction, hemorrhoids, anal fissures, anal bleeding, inflammatory bowel disease, abdominal pain, nausea, vomiting, ulcerative colitis.

Apply rectally.

The gel is introduced into the rectum using a cannula tube (microclema). Remove the protective cap. Insert the pointed part of the cannula tube into the rectum and squeeze out the contents of the entire tube. Remove the cannula tube without loosening the compression.

If necessary, a drop of gel can be used to lubricate the cannula.

Symptomatic treatment of constipation: 1 tube-cannula per day.

Preparation for endoscopic examination of the rectum: 1 tube-cannula 5–20 minutes before the planned time of defecation.

Long-term use is not recommended (if 1–2 single applications are ineffective, treatment tactics should be reviewed).

Pregnant women

Since minimal systemic absorption cannot be excluded with rectal administration, PICOSEN® MICRA should be used during pregnancy only if the benefits outweigh the risks.

Children

Do not use the medicine in children under 18 years of age.

Drivers

Unknown.

May lead to increased side effects.

Gastrointestinal: proctitis, burning sensation in the anus, rectal pain, rectal bleeding.

The presence of glycerin can lead to indigestion and diarrhea.

Hepatobiliary: Cases of hepatotoxicity have been reported with oral administration of docusate sodium, especially in patients concomitantly taking other laxatives.

Skin and subcutaneous tissue disorders: urticaria.

Store at a temperature not exceeding 25°C. Keep out of the reach of children.